Loading company…
StemCyte Taiwan develops cell therapy products and related services.
Founded in 2013, StemCyte Taiwan is a biotechnology company and subsidiary of American StemCyte. It develops cell therapy drugs for conditions including spinal cord injury, acute stroke, and cerebral palsy, and provides cord blood products, cell storage services, and other related offerings. The company has worked with 350 medical centers worldwide and raised TWD 620 million in venture funding in August 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in